Clinical trials recruiting in Pärnu, Estonia
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
Conditions
Phase breakdown
Phase 3 2
Conditions recruiting in Pärnu, Estonia
| Condition | Trials |
|---|---|
| Atherosclerosis Cardiovascular Disease | 1 |
| Chronic Kidney Disease | 1 |
| Metastatic Castration-resistant Prostate Cancer (mCRPC) | 1 |
| Prostate cancer | 1 |
| Prostatic Neoplasms | 1 |
Recruiting trials in Pärnu, Estonia
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Common questions
How many clinical trials are recruiting in Pärnu, Estonia?
2 recruiting trials have at least one study site in Pärnu, Estonia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.